Obestatin and growth hormone reveal the interaction of central obesity and other cardiometabolic risk factors of metabolic syndrome
Abstract Metabolic syndrome (MetS) is a multi-factorial disorder including central obesity (CO), insulin resistance, hyperglycemia, dyslipidemia and hypertension which increases the risk of diabetes mellitus and cardiovascular diseases. CO is considered as an essential component of MetS according to...
Guardado en:
Autores principales: | Angus P. Yu, Felix N. Ugwu, Bjorn T. Tam, Paul H. Lee, Vicki Ma, Simon Pang, Angel S. Chow, Kenneth K. Cheng, Christopher W. Lai, Cesar S. Wong, Parco M. Siu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f2eda47a2514e728e03aea01f260127 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Possible association of ghrelin/obestatin balance with cardiometabolic risk in obese subjects with Helicobacter pylori
por: Ibrahim Azza Saad, et al.
Publicado: (2018) -
Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: the PREDIMED study.
por: Núria Ibarrola-Jurado, et al.
Publicado: (2013) -
Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
por: Boodai SA, et al.
Publicado: (2014) -
Associations of Obstructive Sleep Apnea, Obestatin, Leptin, and Ghrelin with Gastroesophageal Reflux
por: Piotr Pardak, et al.
Publicado: (2021) - Journal of the cardiometabolic syndrome